Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting cancer stem cell propagation with palbociclib, a CDK4/6 inhibitor: Telomerase drives tumor cell heterogeneity

Published:2016-12-25 Issue:6 Volume:8 Page:9868-9884
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Bonuccelli Gloria¹,Peiris-Pages Maria¹,Ozsvari Bela¹,Martinez-Outschoorn Ubaldo E.²,Sotgia Federica³,Lisanti Michael P.³

Affiliation:

1. Paterson Building, University of Manchester, Manchester M20 4BX, United Kingdom

2. The Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA

3. Translational Medicine, School of Environment and Life Sciences, Biomedical Research Centre (BRC), University of Salford, Greater Manchester, M5 4WT, United Kingdom

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A cell cycle centric view of tumour dormancy;British Journal of Cancer;2023-08-22

2. CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties;Signal Transduction and Targeted Therapy;2023-08-16

3. Fumagillin regulates stemness and malignancies in cancer stem-like cells derived from liver cancer via targeting to MetAP-2;PLOS ONE;2023-07-28

4. Targeting Breast Cancer Stem Cells;International Journal of Biological Sciences;2023

5. Plasticity of Cancer Stem Cell;Cancer Stem Cells: Basic Concept and Therapeutic Implications;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP